Her primary scientific interests are in Internal medicine, Risk factor, Prospective cohort study, Relative risk and Myocardial infarction. Her Internal medicine research integrates issues from Endocrinology and Surgery. The various areas that Julie E. Buring examines in her Risk factor study include Epidemiology, Lower risk, Blood pressure, Vascular disease and Physical therapy.
Julie E. Buring has researched Prospective cohort study in several fields, including Cohort study, Environmental health, Proportional hazards model, Hazard ratio and Confounding. Julie E. Buring has included themes like Gastroenterology, Quartile, Lycopene and Cohort in her Relative risk study. In her research, Genetics and Genome-wide association study is intimately related to Disease, which falls under the overarching field of Myocardial infarction.
Julie E. Buring mainly investigates Internal medicine, Prospective cohort study, Endocrinology, Relative risk and Risk factor. Her research integrates issues of Surgery and Oncology in her study of Internal medicine. Her biological study spans a wide range of topics, including Stroke and Myocardial infarction.
Her Prospective cohort study study incorporates themes from Body mass index, Epidemiology, Cohort study, Proportional hazards model and Hazard ratio. Her studies in Relative risk integrate themes in fields like Incidence and Vitamin E. The concepts of her Risk factor study are interwoven with issues in Blood pressure and Cardiology.
Julie E. Buring mainly focuses on Internal medicine, Vitamin D and neurology, Prospective cohort study, Gastroenterology and Body mass index. Her Internal medicine study frequently draws connections to adjacent fields such as Oncology. Her Vitamin D and neurology research incorporates elements of Diabetes mellitus, Placebo, Clinical trial and Fatty acid.
Her Prospective cohort study study combines topics in areas such as Epidemiology, Case-control study and Cohort study. Her Body mass index research is multidisciplinary, incorporating perspectives in Breast cancer, Obesity and Risk factor. Her Randomized controlled trial research is multidisciplinary, incorporating elements of Stroke and Cancer.
Julie E. Buring spends much of her time researching Internal medicine, Prospective cohort study, Vitamin D and neurology, Gastroenterology and Hazard ratio. Her studies link Oncology with Internal medicine. The study incorporates disciplines such as Cohort study, Case-control study, Social isolation, Confidence interval and Obstetrics in addition to Prospective cohort study.
Her work deals with themes such as Young adult and Risk factor, which intersect with Cohort study. She interconnects Placebo and Mood in the investigation of issues within Vitamin D and neurology. Her research in Hazard ratio intersects with topics in Mortality rate, All cause mortality, Confounding and Cadence.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
Paul M Ridker;Charles H Hennekens;Julie E Buring;Nader Rifai.
The New England Journal of Medicine (2000)
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Aruna D. Pradhan;JoAnn E. Manson;Nader Rifai;Julie E. Buring.
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
Paul M. Ridker;Nader Rifai;Lynda Rose;Julie E. Buring.
The New England Journal of Medicine (2002)
Epidemiology in Medicine
Charles H. Hennekens;Julie E. Buring;Sherry L. Mayrent.
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events An 8-Year Follow-Up of 14 719 Initially Healthy American Women
Paul M Ridker;Julie E. Buring;Nancy R. Cook;Nader Rifai.
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.
C H Hennekens;J E Buring;J E Manson;M Stampfer.
The New England Journal of Medicine (1996)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
Colin Baigent;Lisa Blackwell;Rory Collins.
The Lancet (2009)
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women
Paul M Ridker;Nancy R. Cook;I-Min Lee;David Gordon.
The New England Journal of Medicine (2005)
Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women
Paul M. Ridker;Julie E. Buring;Jessie Shih;Mathew Matias.
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score
Paul M Ridker;Julie E. Buring;Nader Rifai;Nancy R. Cook.
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: